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We have characterized cDNA clones representing mouse
CREB (cyclic AMP responsive element binding protein)
mRNA isoforms. These include CREBA and CREBa, of
which the rat and human homologues have been
previously identified. Both encode proteins with CRE-
binding activity and identical transactivation potential.
The additional CREB mRNA isoforms potentially encode
CREB related proteins. From the structural organization
of the mouse CREB gene we conclude that the multiple
transcripts are generated by alternative splicing. Further-
more we show that specific CREB mRNA isoforms are
expressed at a high level in the adult testis. Expression
of these isoforms is induced after commencement of
spermatogenesis. In situ hybridization suggests that this
expression occurs predominantly in the primary sperma-
tocytes. Comparison of the CREB gene with the recently
isolated CREM (cAMP responsive element modulator)
cDNAs illustrates that the two genes have arisen by gene
duplication and have diverged to encode transcriptional
activators and repressors of the cAMP signal transduction
pathway.
Key words: alternative splicing/CREB gene/CREM
gene/gene duplication/spermatocytes
Introduction
In response to extracellular signals, such as hormonal
stimulation, cyclic AMP (cAMP) levels change and lead to
a variety of responses including the alteration of transcription
of many eukaryotic genes. This transcriptional activation is
mediated through cAMP-responsive elements (CRE; Comb
et al., 1986; Montminy et al., 1986; Delegeane et al., 1987;
Silver et al., 1987; Tsukada et al., 1987; Bokar et al., 1988;
Quinn et al., 1988; Fisch et al., 1989; Boshart et al., 1990;
Weih et al., 1990). The CRE is recognized by a family of
DNA binding proteins, the CREB/ATF family, among
which the CRE binding protein (CREB) is best characterized
(Montminy and Bilezikjian, 1987; Deutsch et al., 1988;
Yamamoto et al., 1988). Recently, cDNAs encoding CREB
were isolated from human placenta (Hoeffler et al., 1988)
and from rat brain (Gonzalez et al., 1989), identifying CREB
as a bZIP protein (basic region/leucine zipper protein;
reviewed by Johnson and McKnight, 1989; Kerppola and
Oxford University Press
Curran, 1991). Both the basic region and the leucine zipper
dimerization domain are essential for DNA binding and
transcriptional activation (Dwarki et al., 1990). While the
human and rat cDNA clones were very homologous in their
overall structure, the rat CREB cDNA clone contained an
insertion of 42 bp, termed a. Recently, Yamamoto et al.
(1990) reported the isolation of a rat CREB cDNA clone,
ACREB, from PC12 cells that appeared to be homologous
to the human CREB cDNA clone isolated by Hoeffler et al.
(1988). Although the CREB gene structure was not analysed,
the possibility was discussed that these different cDNA clones
might have arisen by alternative splicing from a single gene
transcript. This hypothesis was supported by the isolation
of both CREB cDNA isoforms in a human T cell cDNA
library (Berkowitz and Gilman, 1990). While rat CREBcr
and CREBA showed a different transactivation potential in
F9 teratocarcinoma cells (Yamamoto et al., 1990) this
difference was not observed in a different test system
(Berkowitz and Gilman, 1990).
We are analysing the hormone dependent and liver-specific
expression of the rat tyrosine aminotransferase (TAT) gene
(reviewed by Nitsch et al., 1991). A cAMP-responsive
element was identified as an essential component of a liver-
specific enhancer of the TAT gene (Boshart et al., 1990)
which was also shown to be the target for the tissue-specific
extinguisher-l (TSE-i; Boshart et al., 1990). Following
stimulation by cAMP we observed increased protein binding
over the TAT-CRE using in vivo footprinting (Weih et al.,
1990) and in vitro binding studies suggested that CREB binds
to this sequence (M.Nichols and F.Weih, unpublished). It
was evident from Northern blot analysis (S.Ruppert,
unpublished) that multiple CREB mRNAs exist, in addition
to the previously identified mRNAs for CREBA (Hoeffler
et al., 1988) and CREBa (Gonzalez et al., 1989). Here we
describe the isolation and characterization of mouse CREB
cDNA and genomic clones. This allows us to analyse the
significance of this CREB mRNA diversity, to identify which
CREB isoforms interact with the TAT-CRE and to elucidate
the particular role of CREB isoforms in the antagonism
between cAMP signalling and TSE-J (Boshart et al., 1990,
1991). Furthermore, knowledge of the structure of the CREB
gene will enable us to manipulate CREB gene expression
by homologous recombination.
Several CREB and CREB related cDNA clones, including
the homologues of the previously reported human and rat
cDNA clones (Hoeffler et al., 1988; Gonzalez et al., 1989;
Berkowitz and Gilman, 1990) were isolated. In addition we
identified other CREB mRNA isoforms which would encode
different CREB related proteins. A detailed analysis of
cDNA and genomic clones proved that the CREB gene
encodes multiple mRNAs which are generated by alternative
splicing. Specific CREB mRNA isoforms are specifically





Isolation and analysis of mouse CREB cDNA clones
reveals many isoforms
We used Northern blotting to analyse RNAs from various
tissues and cells for CREB expression. Under high stringent
conditions multiple mRNAs were identified (data not shown)
suggesting that they may have arisen from the same gene
by alternate processing. To elucidate the nature of these
different RNA species, mouse CREB cDNAs were isolated
from various cDNA libraries (F9 teratocarcinoma, B16
melanoma and liver). A total of 13 different cDNAs, ranging
in size from 1 to > 5.5 kb, were isolated and characterized
by restriction enzyme analysis, crosshybridization to
individual subprobes and by sequencing of their entire coding
regions. A schematic representation of these cDNA clones
is shown in Figure 1.
The most abundant cDNA isoform CREBA, represented
by pmcCREBA, pmcCREB21, pmcCREB36, pmcCREB37
and pmcCREB28, was identified as the mouse homologue
of the human and rat CREB cDNA clones (Hoeffler et al.,
1988; Gonzalez et al., 1989; Berkowitz and Gilman, 1990).
Analyses of the other cDNA clones revealed that they
contained insertions or deletions with respect to the CREBA
isoform changing the coding information. Clones pmc-
CREB27 and pmcCREB41, contain a 42 bp insertion leading
to the incorporation of 14 additional amino acid residues,
termed the a-domain. The rat and human homologues of
these clones have been described in PC12 cells and in T cells
(Gonzalez et al., 1989; Berkowitz and Gilman, 1990). Two
cDNA clones pmcCREB30 and pmcCREB7y, contain another
insertion, the y-domain. This 113 bp insertion occurs at the
identical position as the a-domain. However, due to the
presence of internal translation stop codons it would encode
a protein of only 90 amino acid residues lacking the basic
region and the leucine zipper dimerization domain but
containing the glutamine-rich (Q) domain, postulated to be
involved in CREB mediated transactivation (Gonzalez et al.,
1991). The variant CREB cDNA clone, pmcCREB*, is
characterized by a 175 bp insertion close to its 5' end which
would result in an even shorter product-a 61 amino acid
protein, containing only one half of the Q-domain. The
isoform pmcCREBQ reveals an in-frame deletion of 183 bp
and a variable sequence at its 3' end. This altered sequence
would lead to a modification of the basic region which is
devoid of the leucine zipper dimerization domain. Another
clone, pmcCREB28, contains a short, 11 bp sequence
(5'-GCCTTCTTCAG-3') at its 5' end which occurs exactly
at the exon 1 -intron A boundary. Oligonucleotide hybridiza-
tion has shown that this 11 bp sequence is not present in
the cloned CREB contig (data not shown). It might be
hypothesized that it is part of a far upstream exon which
is transcribed from a different promoter. Clones pmc-
CREB28 and pmcCREB47 contain long extended regions
of 3' noncoding sequences indicating the use of alternate
polyadenylation sites.
Analysis of the structural mouse CREB gene provides
evidence for alternative splicing
In order to understand the basis for the diversity of the CREB
mRNA isoforms, we compared the isolated cDNAs with the
structural organization of the gene. A mouse genomic X DNA
library was screened using the cDNA inserts of pmcCREBWy
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Fig. 1. Schematic representation of the isolated mouse CREB cDNA
clones. cDNA inserts are aligned based upon restriction mapping and
nucleotide sequencing. Boxes denoted a, -y, I and Q indicate
insertions with respect to pmcCREBA. The filled box in pmcCREB28
indicates an additional variation in the 5' untranslated region of CREB,
unique to this cDNA clone. For completeness pmcCREBa which has
been generated in vitro from pmcCREBA is included in this scheme.
and pmcCREB28 as probes and eleven independent X clones
were isolated. All phages formed one overlapping contig and
indicated the presence of one single gene. The cloned DNA
spans more than 80 kb of which - 70 kb comprise the gene
(Cole et al., 1992).
The DNA fragments of the genomic subclones containing
exons were subcloned and partially sequenced using
appropriate designed oligonucleotides derived from the
mouse CREB cDNA sequence. The sequences determined
from the mouse CREB gene, including sequences of the
exon- intron boundaries, are shown in Figure 2. The
genomic sequence did not show any deviation from the
cDNA sequence and all exon -intron boundaries fit perfectly
to the splice consensus sequence (Padgett et al., 1986). In
total 11 exons and 10 introns were identified.
A comparison of the different cDNA species to the
sequential order of the genomic exon sequences indicates
that the different CREB mRNAs were generated by alter-
native splicing of a single gene transcript. This is shown
schematically in Figure 3. The most abundant transcript, the
CREBA isoform (see also Figure 5), is generated by a
splicing reaction in which exon 3 (termed I), exon 5 (termed
a) and exon 6 (termed 'y) are eliminated. For the production
of CREBoa, which differs from CREBA by a 42 bp insertion,
exon 5 (ai) is incorporated. These two mouse CREB cDNA
isoforms are homologous to those which have been described
recently (Hoeffler et al., 1988; Gonzalez et al., 1989;
Berkowitz and Gilman, 1990). The CREB isoform CREB-y
incorporates exon 6 ('y) at the same position where the ax-
domain (exon 5) is incorporated in CREBa. The isoform
CREBcay, identified by PCR analysis (see Figure 5),
represents a combination of these two isoforms which
contains both the a and the ey exons. Another isoform,
CREBI, is the only RNA species identified so far containing
exon 3 (I). The CREBQ isoform deletes exon 3 (1), 4 (ca),
6 (e) and 9, and in addition, it contains a modification of
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CGGCTCCGGGTCGAGCTCGGCTGTTTCCGTGAGTGGCCGTGCGQACTCGG QCT~ GCTGGCTGGCTCCCTGGCTGCGGCTCC CGGCGGCTGCTGCTG
CCTGTGGCCT~~GGGAGAAGCGGAGTGTTGGTGAGTGACGCGGCGGAGGTGTAGTTGACGCGGTGTGTTACGTGGGGGAGAGAATAAAAC:TCCAGCGAGATCCG
GGCCGCGAACGAAAGCAGTGACGGAGGAGCTTGTACCACCG GTAAGAGGAGCAGG... Intron A (16.7 kb)...ACGATCTTCCATATTATTGTM; GTAACTAA
M T BZ S G A D N QQ B G D A A V T Z A Z N Q Q M T V Q A Q P Q I A T L A 37
ATGACCATGGAATCTGGAGCAGACAACCAGCAGAGTGGAGATGCTGCTGTAACAGAAGCTGAAAATCAACAAATGACAGTTCAAGCCCQGCCACAGATTGCCACATTAGCC
Q
CAG GlATAAAAATACATGG....... Intron B (5.7kb)
D N C DT A DG GC C 38
...... .TTTCCTCTTCAATTTGTCAITACAAACAG GACAACATGTGCGACTCTIGCAGATAGTCCTTGC
T T F I Ze P S X I X H D END
ACCACTTATAGAACCAAGTAAAATAAAACATGACTGAAAATAGGACTAGTACAGAAGGCTTTGTGGATGTCTAAGGAAAGGAAACTTCTAG=TAATCTGTGTGTTA
AAGATCACTTGTCTTCAAGAGGCCTTGCTGG CTAGGTATGTCTGCAAC ...............................Intron C(2 Okcb) .............. TGGTCATTGCTTTCTGTGTTCTATASG
V B M P A A H A T BS A P T V T L V Q L P N G Q T V Q V H G V I Q A A Q P 75
GTATCCATGCCAGCAGCTCATGCAACATCATCTGCTCCCQCTGTAACCTTAGTGCAGCTGCCCAATGGGCAGAQAGTCCAGGTCCATGGCGTTATCCAGGCGGCCCAGCCA
S V I Q B P Q V Q T V Q 87
TCAGTTATCCAGTCTCCACAAGTCCAAACAGTTCAG GTATGTGTATAAAAG......... Intron D(0.8kb) ............. TTTATATLTTTACTTCACAG
IB C X D L X R L F S G T Q
TCTTCCTGTAAGGACTTAAAAAGACTTTTCTCCGGAACTCAG GGAGTCCTAGGTCC ...... Intron E(3.4kb) .........ATTGATGACATGCTATGTGCCAt
S L F END
I S T I A Z SS D 96
AG GTGAGGATAAGTGCT............ Intron F(2.4kb) .......... TCAAGATAAAGTTATTCTTTGCTTTCAl ATCAACTATTGCAGAAAGTGAAGAT
S Q Z S V D B V T D S Q X R R Z I L B R R P B Y R 121
TCACAGGAGTCTGTGGATAGTGTAACTGATTCCCAAAAACGAAGGGAAATCCITCAAGGAGGCCTTCCTACAG CTATGTGAITTAATAG... Intron G(4.2kb)..
X I L N D LB S D A P G V P R I Z Z KX S Z Z Z T S A P A 150
AAATAGCTCTTTA=TTCTAG GAAAATTTTGAATGACTTATCTTCTGATGCACCAGGGGTGCCAAGGATTGAAGAAGAAAAGTCAGAAGAGGAGACTTCAGCCCCTGCC
I T T V T V P T P I Y Q T 3 S G Q Y I 169
ATCACCACTGTAACAGTGCCAACCCCCATACCAAACTAGCAGTGGGCAGTACA GGAGTAATACAQ..Intron H(3.3kb)..AAATTCATTGGGTTTTAG TT
A I T Q G G A I Q L A N N C T D G V Q G L Q T L T M T N A A A T Q P G T T 206
GCCATTACCCQGGGAGGAGCAATACAGCTGGCTAACAATGGTACGGATGGGGTACAGGGCCTGCAGACATTAACCATGACCAATGCAGCTGCCQCTCAGCCGGGTACTACC
I L Q Y A Q T T D G Q
ATTCTACAGTATGCACAGACCACTGATGGACA(
Q I L V P S N Q V V V Q A 230
GCAGATTCTAGTGCCCAGCAACCAAGTTGTTGTTCAAG TAATAGAATTAAGAATTCA. ... Intron I(3.lkb)
A S G D V Q T Y Q I R T A P T S T I A P G V V M A S 256
..CTTATACCTTGTTCGCTCTTCTCTGCW& CTGCCTCAGGCGATGTACAAACATACCAGATCCGCACAGCACCCACGAGCACCATTGCCCCTGGAGTTGTTATGGCGTCC
S P A L P T Q P A Z Z A A R K R Z V R L K N RITY R Q T L X C Y G S S M 1280
......
.Intron J (19.5kb) ...... TTTTGTGTTTTTCATTTTT.G
Z A A R I C R R X X X TY V X C (DX N R V A V®IZ N Q N X T D I E L X A 317
GGAGGCAGCAAGAGAATGTCGTAAAGAAGAAGAAGTGAAATGTTTAGAACAATGGCAGTGCTTGAAAACCAAAACAAAACATTGATTGAGGAGCTAAAAGC
KX D L Y C 11 X D fl 327
ACTTAAGGACC=ACTGCCAAATAATATTGGA=AAGTTCTCTCCTGTTACGGTGGAGAATGGACTGGCTTGGCACAACCAGAAAGACAAGTAAACA=A
=TCTAAACA =CTTTT =l- CTATGCGCAAAACTGCCTGAAAGCAACTACAATTATATCTGCTTTTGCATTAAACTGTGAATGTTCCAQACTACTTCC
ACTTCTGCCCTCAAGAAATGTGCAGCGCCAGGAATCATGAAGAGACTITCTGCCCTCCGTCTCCACCACCCTC.AAG;AAGTAATCA=GCTTATTGTAAATTGTTGGGGGA
AATGAGGAAAATGAAATCTTGGCTTTTTC TTGTTTTAGGTTGT
Fig. 2. Nucleotide and deduced amino acid sequence of the mouse CREB cDNA isoforms, including 5' flanking and intron sequences. The sequences
were derived from mouse CREB cDNAs and from genomic subclones. Boxes denoted *, cx, -y and El indicate inserts specific for CREB cDNA
clones pmcCREB*, pmcCREBa, pmcCREBy and pmcCREBQ, respectively. Intron boundaries (GT and AG) are indicated by bold letters. Similar to
the human and rat CREB cDNA sequence (Hoeffler et al., 1988; Gonzalez et al., 1989) we assigned the first ATG of the mouse CREB cDNA as the
translation initiation codon. Immediately upstream is an in-frame translation termination codon. A second ATG within the sequence ACCATO-G, two
amino acid residues C-terminal fits much better the Kozak consensus sequence PuCCATGG (Kozak, 1986) and therefore it is most likely that this
second ATG will be used more efficiently in vivo for translation initiation. The numbering of the amino acid sequence given on the right refers to
the most abundant isoform CREBA. Amino acid residue specific to other CREB isoforms are given in the respective boxes and are not numbered.
Leucines putatively involved in forming the leucine zipper are indicated by circles. Within the initiator sequence Inr 5'-TCCTCAGTCGG-3' (Smale
and Baltimore, 1989), indicated in bold letters the arrow points to the putative transcription initiation site. In the promoter region possible binding
sites for the transcription factor SPI, based on the consensus sequence 5'-GGGCGG-3' (Mitchell and Tjian, 1989) are boxed. Within the 3'
untranslated region the ATTTA motifs, the selective mRNA degradation signals (Shaw and Kamen, 1986; Raymond et al., 1989) are underlined.
exon 10. To generate CREBQl the donor splice site of exon
10 is not used resulting in the incorporation of additional
sequences (see Figure 2). In all other CREB mRNA variants
this splice site is used very efficiently and the 151 bp exon
10 is included. Thus, the mature CREBQ2 species incor-
porates immediately adjacent intron sequences into the
mRNA as deduced by sequence identity of the cDNA clone
pmcCREBQ and the corresponding genomic region (data not
shown).




Fig. 3. Organization of the mouse CREB gene and the alternatively spliced transcripts. Exons, numbered 1-11, are shown as open boxes, 5' and 3'
flanking sequences as lines and introns as disconnected lines. ATG, translation initiation; TAA, translation termination; I, a, (y) and (Q) denote
alternatively spliced exons; b, basic region; ZIP, leucine zipper dimerization domain. For completeness pmcCREBa-y, which has been identified by
PCR analysis (see Figure 5) is included in this scheme. Coding regions are indicated by black boxes; noncoding regions by stippled boxes.
exon 2 z exon4
®A CEE MTME3GADNQ GDAAVTEAEgQQMT )QI LAVSMPAAHATSSAPTVTLVQLPNGQTVOVHGVIQAAQPSVIQSPQVQTVQ 87
CREIM MTMETVESQDRSVTRSVMHSS ABtr(Isv T 38
exon 7 *YI* exon 8
CREB I 4 E;EE 1VD 1'QT ILSRRPSYRKIL LS i IEKSEEP SAAIT YQT Q IAITQGG 175
CREM v IAEDADE ILSRRPSYRKIL LSSEKEE TPIPNIA YQTS 117
exon 9 exon 10
CRWD AIQLANNGTDGVQGLQTLTMTNAAATQPGTTILQYAQTTDGQQILVPSNQVVVQP;EVUIF THBI PNMS AL 260CREM (NEETDLAPSHMAA) MYQI ALPPGSLHS 149
exon 10 - I*exonl1
CRE CRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCH D Stop 327
CREARCRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCH Stop 217
E A A R E C R R X X K E Y V K C L E N R
BiA CREB TTTTTTTGTGTTTTTCATTTTTAG GGAGGCAGCAAGAGAATGTCGTAGAAAGAAGAAAGAATATGTGAAATGTTTAGAGAACAGA0__J CREM CCCTTCTGCTTCTACTTTTTTCAG GGAAGCTGCTAAAGAATGTCGACGTCGAAAGAAAGAGTATGTGAAGTGTCTTGAGAGTCGA
E A A K Z C R R R K K E Y V K C L E S R
1 2 3 4 5 6 7 8 9 10a, b 11
CREB Gene _ - _
CpG ATG ' a y PK-C/PK-A CKII b,Q b, ZIP/TM
Q Q DLSSD b, ZIP/TAA/b, ZIP
CREM Gene .-7: EZ 2AU ir
? 2 ??? 7 8 9 10 lla, b
Fig. 4. Comparison of the mouse CREB gene with the CREM cDNA sequences indicates homology in the gene structure. (A) Comparison of the
327 amino acid sequence of mouse CREBA and the 217 amino acid sequence of CREM7y (Foulkes et al., 1991) in the one letter amino acid code.
For optimal alignment gaps have been introduced. Numbers of amino acids are given on the right. Boxed amino acids indicate sequence identity. The
positions of arrows indicate exon-intron boundaries identified in the mouse CREB gene (Figure 2). The 12 amino acid sequence present in mouse
CREMca and CREM,B and absent in CREM-y, which exhibits no obvious homology to mouse CREB exon 9, is given in parentheses. (B) Nucleotide
sequence comparison of the mouse CREB exon 11 and the sequence of the leucine zipper domain II of the CREMa cDNA clone indicates that the
exon-intron boundary occurs at the identical position. For both regions part of the intron sequence and part of the exon sequence with the amino
acid sequence are shown. The consensus AG of the splice site is shown in bold letters. (C) Schematic representation of the genomic organization of
the mouse CREB and CREM genes. Introns, shown as disconnected lines, are not drawn to scale. Exons are indicated by numbers with additional
highlighted features: CpG, CpG rich exon; ATG, translation initiation; Q, glutamine-rich transactivation domain; I, a, -y and Q, alternatively spliced
exons of the CREB gene; DLSSD, additional transactivation domain; PK-C. protein kinase C consensus sequence; PK-A, protein kinase A consensus
sequence; CKII, casein kinase II consensus sequence; b, basic region; ZIP, leucine zipper dimerization domain; TAA, translation termination(Hoeffler et al., 1988; Gonzalez et al., 1989, 1991; and this work). Striped boxes denote exons which are homologous between CREB and CREM.
Black boxes indicate exons which are alternatively spliced in either CREB or CREM transcripts. White boxes denote exons which have been
identified for the CREB gene but not for the CREM gene.
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restriction enzymes identified a CpG island (Bird, 1987) at
the 5' end of the cloned contig (Cole et al., 1992).
Subsequent DNA sequence analysis indicated that the
putative mouse CREB gene promoter also resides in this CpG
rich RNA region (Figure 2). There is no suppression of
methylatable CpG dinucleotides, i.e. the percentage of CpG
dinucleotides within the sequenced region is identical to GpC
dinucleotides, which is thought to be indicative for promoters
of housekeeping genes (Bird, 1987). The CREB gene
promoter is devoid of obvious TATA or CCAAT box
sequences, but possesses multiple putative binding site for
the transcription factor SPI (see Figure 2; Mitchell and Tjian,
1989). Within the putative promoter region we noticed the
nucleotide sequence 5'-TCCTCAGTCGG-3', closely
resembling the Inr (initiator) sequence 5'-PyCCTCAPy-
TCTG-3', which has been identified by Smale and Baltimore
(1989) to represent a discrete element in RNA polymerase
II transcribed promoters lacking a TATA box. This element
can act either alone or in concert with upstream elements,
greatly increasing specific transcription initiation at the
conserved A nucleotide within the Inr (Smale and Baltimore,
1989). Two SPI binding sites are located at positions -36
and + 36 with respect to the A in the Inr (Figure 2). This
would be a favourable distance (Smale and Baltimore, 1989)
to allow strong transcription from the CREB gene promoter.
One of the major transcriptional start sites of the CREB gene
was indeed mapped to the Inr sequence (Cole et al., 1992).
The mouse CREB and CREM genes are highly
homologous
Recently, Foulkes et al. (1991) reported the isolation of a
gene, termed CREM (cAMP-responsive element modulator),
encoding a protein highly homologous to the nuclear factor
CREB. Within one cDNA clone, CREMa, they identified
two almost identical DNA binding/leucine zipper domains
of which the second motifwas out of frame. By PCR analysis
they detected a second CREM isoform, CREMJ, in which
this second DNA binding/leucine zipper motif was in frame.
By DNA sequence analysis of the genomic region and by
hybridization of a specific probe for the CREB leucine zipper
domain, the presence of such a second leucine zipper motif
was not evident in the cloned CREB contig (data not shown).
Although the genomic CREM contig was not characterized,
Foulkes et al. (1991) speculated that these CREM isoforms
were generated by alternative splicing.
Knowledge of the genomic structure of the CREB gene
strongly supports this hypothesis. The CREB exon 2,
containing the ATG translation initiation codon, is identical
in size and is similar in its amino acid composition to that
of CREM (Figure 4A). Furthermore, by aligning the amino
acid sequences of CREB and CREM we observed that
homologous regions can be unambigiously assigned to
individual exons identified for the mouse CREB gene (see
Figures 2-4). It was obvious that in addition to the
homology in exon 2 the corresponding sequences of exons
7, 8, 10 and 11 are nearly identical (Figure 4A). The
homology of CREM to CREB breaks off exactly at the
positions of identified CREB exon boundaries. The size of
the CREM protein isoform CREM-y (217 amino acid
residues) is also in agreement with the overall coding capacity
of the CREB exons 2, 7, 8, 10 and 1. The 12 unique amino
acid residues of the CREMa, missing in CREB'y (Foulkes
Fig. 5. PCR analysis of CREB isoform transcripts reveals high
expression of CREB-y mRNA in testis and identifies a new mRNA
isoform, CREBcry. (A) Schematic representation of part of the mouse
CREB gene. Boxes numbered 4-8 indicate exon sequences. Introns
are shown as disconnected lines. The position and direction of the two
PCR primers located in exon 4 and 8 are indicated by arrows. The
asterisks denotes the position of the oligonucleotide used as a probe for
hybridization in B. The expected exon compositions and sizes of the
CREB isoforms are indicated. (B) Southern blot hybridization analysis
of PCR products. The mouse, rat and human tissues and cell lines
used as a source of RNA preparation, for reverse transcription and
subsequent PCR are indicated above the lanes. Plasmids used as
controls were pmcCREB-y (-y), pmcCREBA (/v) and pmcCREBa (a).
Arrows on left point to A, a,(y and c-y specific amplification
products. The PCR products were hybridized with an oligonucleotide
indicated by the asterisks in A, detecting all CREB isoforms. For
unambiguous assignment of individual CREB isoform structures within
the amplified DNA fragments, the PCR products were analysed in
addition by Southern blot hybridization using CREB isoform-specific
oligonucleotides as probes (see Materials and methods; data not
shown). (C) Southern blot hybridization analysis of PCR products
from testis RNA. Polyadenylated RNA for reverse transcription and
subsequent PCR was prepared from testis of 8-day-old and adult mice.
PCR was performed as in (B) at various cycles of amplification as
indicated. Arrows on the left point to A, a, ey and c-y specific
amplification products. The PCR products were hybridized with an
oligonucleotide indicated by the asterisks in A, detecting all CREB
isoforms. Plasmids used as controls were as described in (B).
et al., 1991) and occurring at the equivalent position of
CREB exon 9 (encoding 61 amino acid residues) reveals no
obvious homology to the mouse CREB gene and therefore
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Fig. 6. CREB is specifically expressed in primary spermatocytes. (A) Dark-field photograph of a cryostat section from mouse testis hybridized with a35S-labelled riboprobe as described in Materials and methods. The bar represents 200 ztm. (B) Same as A but bright-field photography showingstrong hybridization signals in the outer cell region of a single tubulus. The bar represents 65 itm. (C) Bright-field photography of paraffin embeddedmouse testis. Strongest hybridization is observed in cells identified as spermatocytes I. Secondary spermatocytes and mature spermatides revealexpression levels close to background. The bar represents 23 ,um.
CREM gene. Also note that exon 9 of the mouse CREB gene
is alternatively spliced in the CREBQ isoform (Figure 3).
As inferred from the CREMa cDNA isoform (Foulkes
et al., 1991), the overall similarity in the gene structure
between CREB and CREM is best documented by the
exon - intron boundary of CREB exon 1 1. This exon - intron
boundary separating the basic region from the leucine zipper
domain is positioned in the CREB gene where the sequences
of the two isoforms ofCREM begin to diverge (Figure 4B;
Foulkes et al., 1991). The striking homologies described
here, lead us to postulate a similar genomic organization for
both the CREB and the CREM gene (see Figure 4C and
Discussion).
Specific expression of CREB isoforms in the testis
Isolation of multiple CREB isoforms from a single cDNA
library (for example cDNAs corresponding to CREBA,
CREBa, and CREB'y were isolated from a F9 terato-
carcinoma cDNA library and CREBA, CREBy, and CREBQ
isoforms were isolated from a B16 melanoma cDNA library)
suggests that multiple isoforms are expressed within the same
cell. To characterize further the expression of CREBisoforms, we used reverse transcription/PCR and in situ
hybridization to analyse expression in various tissues and
cell lines. To detect expression ofCREB isoforms in RNAs
prepared from mouse, rat and human samples primers were
chosen from conserved sequences located in exon 4 and exon
8 (see Figure 5A and Materials and methods). The results
of this PCR analysis, shown in Figure 5B, clearlydemonstrate that CREBa and CREBA are expressed in all
tissues and cell lines tested. CREBA showed a 3 to 5-foldhigher level of expression compared to CREBca, reflectingthe relative abundance of the two isoforms isolated by cDNA
screening (Figure 1) and correlates with the RNAse
protection experiments of Berkowitz and Gilman (1990).With the exception of human melanoma cell lines tested, the
y-isoform is also ubiquitously expressed, however, at a lower
level compared to CREBA and CREBa. In addition to the
A-, a- and y-isoforms, hybridizations to defined
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called CREBa-y, which was not isolated by our cDNA
screening. All tissues and cell lines expressing the a- and
'y-isoforms also expressed this CREBa-y isoform but at a
low level.
Surprisingly, we found a high level of expression of the
-y isoforms in testis. Since it was observed that specific
isoforms of the CREM gene are generated by alternative
splicing during testis differentiation (Foulkes et al., 1992),
the expression of CREB isoforms in testis was analysed
further before and after the onset of spermatogenesis. Testis
RNA from 8-day-old and adult mice was analysed by reverse
transcription/PCR as described above at different PCR cycle
numbers. Results are shown in Figure SC. In testis RNA
from 8-day-old mice the level of expression of the 'y- and
ca'y- isoforms was found to be similar to that of other tissues
tested. In adult mice, after the onset of spermatogenesis,
levels of the -y- and ao'y- isoforms increased dramatically to
a similar level of the A- and a- isoforms. To be certain that
our PCR reaction only amplified DNA fragments arising
from CREB mRNAs, another CREB-specific 5' PCR primer
from CREB exon 2 and a CREM-specific primer from the
homologous part of the CREM gene was prepared. PCRs
were repeated on testis RNA samples and confirmed the
amplification and detection of only CREB-specific PCR
products (data not shown).
Northern blot analysis detected a high level of CREB
expression in testis and brain (data not shown). We were
particularly interested in identifying the cell types expressing
the CREB gene and therefore analysed expression of CREB
mRNA by in situ hybridization. Whereas CREB gene
expression in brain does not show any cell type preference
(data not shown), CREB mRNA is abundant in a defined
region of the testis (Figure 6A). The primary spermatocytes
(predominantly those of the pachytene stage) express high
CREB mRNA levels (Figure 6B and 6C) whereas the
secondary spermatocytes and mature spermatids either do
not express CREB or express it at an undetectable level.
Thus, based on our PCR analysis (Figure 5) which showed
a high expression of the -y-isoform, we conclude that the
primary spermatocytes express higher levels of the CREB'y
and CREBa7y mRNA isoforms in addition to CREBA and
CREBa.
CREBa and CREBA display identical transactivation
potentials
The differentially spliced CREB isoforms with intact DNA
binding and dimerization domains, CREBa and CREBA,
were tested for their CRE-mediated transactivation potentials
in the transient cotransfection assay used by Gonzalez and
Montminy (1989). We compared cDNA isoforms differing
solely by the inclusion of individual exon sequences within
an otherwise identical sequence content. Full-length mouse
cDNAs for CREBa and CREBA, cloned into the eukaryotic
expression plasmid pHD (Muller et al., 1988), were
cotransfected into F9 teratocarcinoma cells together with the
somatostatin promoter-CAT plasmid (A(-71)SOM-CAT;
Montminy et al., 1986) as a reporter and an expression
plasmid encoding the catalytic subunit of protein kinase A
(PKA) (Uhler and McKnight, 1987). With increasing
amounts of the CREB expression plasmids we observed a
steady increase of transactivation with both CREB isoforms,
up to 70-fold (Figure 7). A much lower, but significant
transactivation was observed when the catalytic subunit of
-0O-- CREBa + RllI
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Fig. 7. The isoforms CREBcS and CREBA have similar transactivation
potentials. Increasing amounts of CREBa and CREBA expression
plasmids were cotransfected with a somatostatin promoter construct
(W(-71)SOM-CAT; Montminy et al., 1986) as a reporter, together
with expression plasmids encoding either the catalytic (Ca) or
regulatory (RII,) subunit of protein kinase A into undifferentiated F9
teratocarcinoma cells. CAT activities are corrected for 3-galactosidase
activity of an internal reference and calculated as fold stimulation,
setting the control without CREB expression plasmnid to 1.
protein kinase A was omitted (data not shown) or when the
regulatory subunit RlIl (Buchler et al., 1990) was
cotransfected (Figure 7). We conclude that the mouse
CREBa and CREBA proteins are equally able to trans-
activate a CRE-containing reporter construct in this
cotransfection system.
As the CREBWy isoform lacks the DNA binding domain
and the leucine zipper (see Figure 2) but contains the
glutamine-rich transactivation domain (Gonzalez et al.,
1991; Courey and Tjian, 1988) we considered the possibility
that this form could function by modulating CREB activity,
e.g. in a dominant negative fashion, like squelching (Ptashne,
1988). Therefore an expression plasmid encoding CREB7y,
pHDmCREBy, was cotransfected with the A(-7 1)SOM-
CAT reporter plasmid into rat PC 12 cells which contain
endogenous CREB (Yamamoto et al., 1990). No effect of
CREB-y on CRE-mediated transcription could be detected
(data not shown).
Discussion
Functional significance of mouse CREB mRNA
isoforms generated by alternative splicing
Six different mouse CREB mRNAs, CREBA, CREBa,
CREBWy, CREBay, CREBk and CREBQ, which differ in
their coding information were identified. These isoforms are
generated by alternative splicing of a single primary gene
transcript and lead to the inclusion or exclusion of different
exon sequences, termed ', ca, ey and Q(. CREBA and
CREBa are the most abundant CREB isoforms. CREBA,
which was expressed in all cells and tissues tested, encodes
a protein of 327 amino acids (Figure 2). Incorporation of
the a-domain, yielding CREBa, does not interfere with the
amino acid reading frame, however, inclusion of the exon
sequences designated 'I and a would lead to termination of
translation upstream of the assigned stop codon (Figure 2).
The generation of multiple mRNA transcripts of a single
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gene by alternative splicing has been documented for a
variety of transcription factors, including the CCAAT box
binding proteins CTF/NF-1 (Santoro et al., 1988), retinoic
acid receptors at, and -y (Leroy et al., 1991; Zelent et al.,
1991; Krust et al., 1989), the Oct-2 gene (Wirth et al., 1991)
and most likely the CREM gene (Foulkes et al., 1991,
1992). Differential activities of alternate CTF/NF-1 isoforms
have been described (Santoro et al., 1988), but in many cases
the cell and tissue-specific expression and the functional
significance of various isoforms of a particular gene is not
known.
We analysed the two CREB isoforms, CREBaz and
CREBA, which include the basic region and the leucine
zipper dimerization domain, in a transactivation assay. Both
mouse CREB isoforms showed a very similar potential to
transactivate a CRE-containing reporter construct in
undifferentiated F9 cells (Figure 7). This result is in
agreement with transfection experiments performed by
Berkowitz and Gilman (1990). They transfected human
CREBa and CREBA isoforms, combined with the DNA
binding domain of the yeast transcriptional activator protein
GAL4 into BALB/c3T3 cells and also did not observe a
functional difference between these CREB isoforms.
However, in one report using rat CREB isoforms, the a-
domain was implicated in enhancing CREB mediated
transactivation from a somatostatin promoter-CAT
construct (Yamamoto et al., 1990). As mouse and rat CREB
proteins are very similar, we do not consider the possibility
that the different outcome of our experiments and those
described by Yamamoto et al. (1990) could be attributed to
the minor amino acid residue exchanges. Thus, at least by
these experiments the role of the ca-domain in transactiva-
tion seems to be questionable.
The incorporation of exon 3 (') or exon 6 (-y) into the
mature mRNA would generate shorter CREB proteins,
lacking DNA binding and leucine zipper domains. These
proteins would include the glutamine-rich transactivation
domain (CREBy) and in addition the a-domain (CREBacy).
The abundance of the CREBy mRNA isoform in a specific
cell type, e.g. the primary spermatocytes of the testis (see
below), might be taken as an argument for a specific role.
Some transcription factors such as SP1, Oct-I and Oct-2
stimulate transcription through similar glutamine-rich do-
mains (Courey et al., 1989; Tanaka and Herr, 1990). This
suggests that CREB-y might downregulate CREB mediated
activation by acting as a transdominant inhibitor (Ptashne,
1988). In a series of cotransfection experiments, however,
we could not obtain evidence to support this hypothesis.
Thus, whereas CREBA and CREBa encode transcription
factors with DNA binding activity and transactivation poten-
tial (Figure 7), the functional significance of additional CREB
isoforms in the cAMP signalling process remains elusive.
Specific CREB mRNA isoforms are more highly
expressed in primary spermatocytes
Elevated expression of the CREB gene was detected in
primary spermatocytes by in situ hybridization (Figure 6)
and expression of at least four CREB mRNA species,
CREBA, CREBa, CREB-y, and CREBay, has been
demonstrated by PCR in testis (Figure 5). In all other cells
and tissues tested, mRNAs for the CREB-y and CREBa-y
isoforms are minor splicing variants. During spermatogenesis
a significant switch in splicing of CREB transcripts leads
to higher levels of these two CREB mRNA isoforms and
suggests a specific function for these isoforms in spermato-
genesis. As discussed above, the functional implication of
splicing products like CREB-y and CREBae-y in the cAMP
signalling pathway remains elusive. Nevertheless, we can
speculate that the switch to generation of higher levels of
CREB-y mRNAs in testis may reflect an initial event of
downregulation of CREB-mediated gene expression by
lowering mRNA species encoding active CREB forms.
Consistent with this is the observation that the regulatory
subunit RI, of PKA, which when bound to the catalytic
subunit prevents activation of CREB by phosphorylation,
shows a particularly high level of expression in the primary
spermatocytes (Oyen et al., 1987). Both the high level of
CREB-y isoforms and RI,, expression would lead to a
reduction in CREB-dependent gene transcription. The
CREM gene has recently been shown to be expressed in testis
where cell-specific alternative splicing generates a novel
CREM isoform, called CREMT (Foulkes et al., 1992).
Unlike the previously characterized CREM isoforms, a, (,
and ry which function as antagonists of the cAMP trans-
cription activation pathway, CREMT functions as a
transcriptional activator. During the onset of spermatogenesis
there is an abrupt switch in CREM gene expression from
the generation of the CREM antagonists to the generation
of the CREMr activator. Therefore this coincides with the
generation of CREB7y isoforms in testis. Taken together with
the similarities in gene structure of CREB and CREM, this
may reflect a common regulatory switch in the mechanism
of alternate splicing for these two genes leading to production
of a CREM activator and down regulation of CREB
activation functions.
The CREB and CREM gene have a similar organization
in genomic structure
Determination of the structural organization of the mouse
CREB gene has allowed alignment of similar regions of
CREB mRNAs to the defined exons of the CREB gene. The
structural organization of the mouse CREM gene has yet
to be determined but based on these comparisons we suggest
a similar gene structure for the mouse CREM gene
(Figure 4C). The DNA binding and leucine zipper dimeriza-
tion domains of CREB and CREM are nearly identical and
both bind to a CRE with the same affinity (Foulkes et al.,
1991). The similarity in structural organization is also in
keeping with the speculation made by Foulkes et al. (1991)
that expression of the CREM gene is subject to alternate
splicing.
Recent characterization of another isoform of the CREM
gene, called CREMT (Foulkes et al., 1992), strengthens the
similarity found between CREM and CREB. CREMT
contains two additional segments, compared with the other
CREM isoforms and these two insertions correspond to
exons 4 and 9 of the CREB gene. In structure CREMT most
closely resembles CREBA. Unlike the other CREM
isoforms, but similar to CREB, CREMr is an activator of
the cAMP induced signal transduction pathway. The inserted
sequence in CREMT similar to exon 4 of CREB is rich in
glutamine residues. This domain has recently been implicated
in the transactivation function of CREB (Gonzales et al.,
1991). The presence of the second inserted sequence in
CREMT, similar to exon 9 of CREB, could be important
in correct spacing of domains and thus important in
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transactivation. The isoforms in CREM, having an
antagonistic action on the cAMP induction pathway, lack
these two domains implicating further these two regions in
mediating a transactivating function. Therefore for the
CREM isoforms the presence or absence of these specific
domains could explain their function as repressors or
activators of transcription. Most putative phosphorylation
sites are well conserved between CREB and CREM but one
within the pDE-1 domain of CREB (amino acid residues
92-108, Lee et al., 1990; Figure 4) has only a weak
homology to CREM. Lee et al. (1990) showed that this
domain is the target for a protein kinase other than PKA
and that it is required absolutely for the transactivation
function of CREB. Differences in phosphorylation between
CREB and CREM may be important in dictating specific
transactivating functions.
The apparent homology in the CREB and CREM gene
structure and the strong sequence conservation imply that
these two genes have arisen by duplication of an ancestral
gene. The CREB gene has developed alternative splicing of
exons to generate isoforms able to activate transcription via
the cAMP induction pathway. The CREM gene, however,
though a similar splicing mechanism has developed to encode
isoforms able to activate or repress gene expression also via
the cAMP signal transduction pathway. Future experiments
involving domain swapping between CREB and CREM may
help to elucidate the functional difference between specific
domains of CREB and CREM.
Materials and methods
Isolation and characterization of mouse CREB cDNAs
Mouse B16 melanoma, newborn mouse liver and mouse F9 teratocarcinoma
cDNA libraries were constructed as described (Ruppert et al., 1988, 1990;
Scholer et al., 1990). 5 x 105 original pfu of the XgtlO liver cDNA library
and 5 x I05 original pfu of the XgtlO/Xgtl 1 B16 melanoma cDNA libraries
were screened with a human placental CREB cDNA clone (GI-CREB;
Hoeffler et al., 1988) using hybridization conditions as described (Ruppert
et al., 1990). XmcCREB1 1 was isolated from the liver cDNA library and
subcloned into Bluescript M13- (Stratagene), yielding pmcCREBI. The
EcoRI inserts of XmcCREB42 and XmcCREB61, isolated from the B16
melanoma cDNA library, subcloned into Bluescript M13- (Stratagene)
yield pmcCREBQ2 and pmcCREB-y, respectively. 4 x 106 original pfu of
the F9 teratocarcinoma cDNA library, containing directionaly cloned
EcoRI-XhoI cDNA fragments in the cDNA expression vector XZAPII
(Stratagene) were screened with radiolabelled pmcCREB-y probe. Ten
independent XcDNA clones were isolated and the inserts were rescued by
the zapping procedure (Short et al., 1988), yielding the plasmid cDNA clones
pmcCREB4 (subsequently termed pmcCREBz), pmcCREB2 1,
pmcCREB36, pmcCREB37, pmcCREB2, pmcCREB28, pmcCREB47,
pmcCREB27, pmcCREB41 and pmcCREB30. DNA sequences of CREB
cDNA inserts were determined using T3 and T7 promoter-specific
oligonucleotides. All cDNA clones were completely sequenced in their coding
region by using appropriate oligonucleotides as primers. Sequencing was
performed according to Sanger et al. (1977) with modifications described
by Luckow and Schiutz (1991). Details on the isolation and characterization
of the structural mouse CREB gene, generation, characterization and
sequencing of genomic subclones are available on request.
Construction of pmcCREBa and CREB expression plasmids
We constructed pmcCREBa by site directed in vitro mutagenesis according
to the method described by Taylor et al. (1985). The ca-domain was
introduced into pmcCREBA using the oligonucleotide 5'-CCAGTCTCC-
ACAAGTCCAAACAGTTCAGTCTTCCTGTAAGGACTTAAAAA-
GACTTYI7CTCCGGAACTCAGATTTCAACTATTGCAGAAAG-3',
including the sequence information for the a domain (bold letters) plus
flanking sequences derived from the cDNA clone pmcCREB27. The resulting
cDNA clone pmcCREBa was sequenced completely in the coding and 5'
noncoding region. The EcoRI-AoI cDNA inserts of pmcCREBA and
pmcCREBa were made blunt-ended and cloned in either orientation into
the SnaI site of the eukaryotic expression plasmid pHD (Muller et al., 1988)
to generate pHDmCREBA, pHDmCREBa, (sense orientation),
pHCmBERCA and pHDmBERCa (antisense orientation), respectively. The
SmaI cDNA fragment of pmcCREB-y was cloned into SmaI cut pHD to
yield pHDmCREBy.
Amplification of RNA and DNA by PCR
cDNA was synthesized from either 1 jig poly(A)+ RNA or from 5 jg total
RNA in a 20 Id reaction containing 50 mM Tris-HCI (pH 8.3), 75 mM
KCI, 3 mM MgC12, 1 mM dithiothreitol, each 0.5 mM dNTP, 25 jig/ml
oligo d(T), 30 U RNasin (Stratagene) and 200 U reverse transcriptase
(Superscript, BRL). After incubation for 1-2 h at 37°C the samples were
diluted to 100 jil with TE (10 mM Tris-HCI (pH 7.5), 0.1 mM EDTA)
and 5 jIl were used for PCR analysis. 50 Il PCR reactions were performed
including 7 jil PCR-buffer (100 mM Tris-HCI (pH 8.3), 500 mM KCI,
0.1% gelatine, 15 mM MgCI2, 0.1% Tween 20, 0.1% Triton X-100, 1%
NP40), each 0.2 mM dNTP, 0.5 jiM of each primer (oligo A: 5'-CCAG-
TCTCCACAAGTCCAAACAG-3', CREBA cDNA position corresponding
to amino acid residues 79-87, exon 4 and oligo B: 5'-GGCACTG-
TTACAGTGGTGATGG-3', CREBA cDNA position corresponding to
amino acid residues 150-157, exon 8) and 2 U of Taq DNA polymerase
(Perkin-Elmer Cetus). As control lo-, pmol of control plasmids
pmcCREBa, pmcCREBA and pmcCREB-y were amplified. The following
temperature profile was used: 1 min at 92°C, 1 min at 50°C and 1.5 min
at 72°C; the last cycle was performed for 10 min at 72°C. After 21, 24,
27 and 30 cycles aliquots were removed and analysed on a 2% agarose
gel. To identify CREB related amplification products Southern blotting and
hybridization were performed using internal oligonucleotides as specific
probes: oligo C: 5'-GAAAA1TTTTGAATGAC-3', CREBA cDNA position
corresponding to amino acid residues 122 - 126, exon 8; oligo D:
5 '-TTCATGAGAACAGAGATGTACTGTTTGTTCACTGCTGCCT-
TTGAT-3', CREB-y cDNA position corresponding to nucleotide residues
18-62 of exon 6 ('y); oligo E: 5'-AGTTCCGGAGAAAAGTCTTT-
TTAAGTCCTTACAGGAAGACTG-3', CREBca cDNA position
corresponding to nucleotide residues 1 - 39 of exon 5 (ca) and the last three
nucleotide residues of exon 2.
A specific probe for the CREB leucine zipper was prepared by PCR using
pmcCREB37 as a template. The Bluescript SK- (Stratagene) T7 primer
and the CREB specific primer 5'-AAGAACAGGGAGGCAGCAAGA-3'
(CREBA cDNA position corresponding to amino acid residues 278-284)
were used as primers. PCR was performed as described before using the
temperature profile: 1 min at 92°C, 1 min at 45°C and 1 min at 72°C.
In situ hybridization
Brain and testis of adult mice were isolated, washed in PBS and immediately
fixed in 4% paraformaldehyde or shock frozen in isopentane/liquid nitrogen.
In situ hybridization experiments were performed on paraffin-embedded
tissue sections and on cryostat sections as described (Duboule and Dolle,
1989; Ruppert et al., 1990) using in vitro generated 35S-labelled antisense
and sense RNA probes derived from pmcCREB30. After 2-4 weeks
exposure the sections were developed with Kodak D19 and counter-stained
with hematoxylin and eosin.
Cotransfection assay
F9 teratocarcinoma cells were grown in DMEM supplemented with 10%
fetal calf serum on gelatin coated dishes. 1.2 x 10 cells per 60 mm dish
were transfected by the calcium phosphate method (Graham and van der Eb,
1973). The precipitate contained 2 jg reporter plasmid (A(-71)SOM -CAT;
Montminy et al., 1986), 2 jig of a metallothionein promoter-driven
expression construct encoding either the mouse catalytic subunit, C"', of
PKA (CaEV; Uhler and McKnight, 1987) or the human regulatory subunit
RII, (REV; Buchler et al., 1990), 1 jig RSVIacZ as internal reference and
0-5 jig of mouse CREB expression plasmids pHDmCREBa or
pHDmCREBA. The precipitate was added 3-4 h after plating and left on
the cells over night, followed by a medium change. The total amount of
transfected DNA was adjusted to 10 jig by addition of pHDmBERCa which
contains the CREB cDNA insert in the antisense orientation but is otherwise
identical to pHDmCREBa. After 45 h, extracts were prepared and CAT
assays and 13-galactosidase assays were performed as described (Boshart
et al., 1990). CAT activities were corrected for,B-galactosidase activity in
the same extract and calculated as fold stimulation, setting the control which
had received no CREB expression plasmid arbitrarily to 1.
PC 12 cells were grown as described by Montminy et al. (1986) and
electroporated under the conditions described by Boshart et al. (1990) withjg A(-71)SOM -CAT (Montminy et al., 1986), 2 jig RSVlacZ and 12 jg
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